scholarly journals Frequent Occurrence of an Intron 4 Mutation in Multiple Endocrine Neoplasia Type 1

2002 ◽  
Vol 87 (6) ◽  
pp. 2688-2693 ◽  
Author(s):  
Jeremy J. O. Turner ◽  
Poloko D. Leotlela ◽  
Anna A. J. Pannett ◽  
Simon A. Forbes ◽  
J. H. Duncan Bassett ◽  
...  

MEN1 is an autosomal dominant disorder characterized by parathyroid, pituitary, and pancreatic tumors. The MEN1 gene is located on chromosome 11q13 and encodes a 610-amino acid protein. MEN1 mutations are of diverse types and are scattered throughout the coding region, such that almost every MEN1 family will have its individual mutation. To further characterize such mutations we ascertained 34 unrelated MEN1 probands and undertook DNA sequence analysis. This identified 17 different mutations in 24 probands (2 nonsense, 2 missense, 2 in-frame deletions, 5 frameshift deletions, 1 frameshift deletional-insertion, 3 frameshift insertions, 1 donor splice site mutation, and a g→a transition that resulted in a novel acceptor splice site in intron 4). The intron 4 mutation was found in 7 unrelated families, and the tumors in these families varied considerably, indicating a lack of genotype-phenotype correlation. However, this intron 4 mutation is the most frequently occurring germline MEN1 mutation (∼10% of all mutations), and together with 5 others at codons 83–84, 118–119, 209–211, 418, and 516, accounts for 36.6% of all mutations, a finding that indicates an approach for identifying the widely diverse MEN1 mutations.

2017 ◽  
Vol 48 (S 01) ◽  
pp. S1-S45
Author(s):  
O. Schwartz ◽  
J. Althaus ◽  
B. Fiedler ◽  
K. Heß ◽  
W. Paulus ◽  
...  

1994 ◽  
Vol 4 (3) ◽  
pp. 199-207 ◽  
Author(s):  
N. M. Pastor-Soler ◽  
M. A. Rafi ◽  
J. D. Hoffman ◽  
D. Hu ◽  
D. A. Wenger

2009 ◽  
Vol 10 (1) ◽  
Author(s):  
Kyoko Kanda ◽  
Kandai Nozu ◽  
Naoki Yokoyama ◽  
Ichiro Morioka ◽  
Akihiro Miwa ◽  
...  

Genomics ◽  
1988 ◽  
Vol 2 (1) ◽  
pp. 32-36 ◽  
Author(s):  
Hagop Youssoufian ◽  
Haig H. Kazazian ◽  
Achyut Patel ◽  
Sophia Aronis ◽  
George Tsiftis ◽  
...  

Genes ◽  
2020 ◽  
Vol 11 (8) ◽  
pp. 924
Author(s):  
María-José Morán-Jiménez ◽  
María-José Borrero-Corte ◽  
Fátima Jara-Rubio ◽  
Inmaculada García-Pastor ◽  
Silvia Díaz-Díaz ◽  
...  

Acute intermittent porphyria (AIP) results from a decreased activity of hepatic hydroxymethylbilane synthase (HMBS), the third enzyme in the heme biosynthetic pathway. AIP is an autosomal dominant disorder with incomplete penetrance, characterized by acute neurovisceral attacks precipitated by several factors that induce the hepatic 5-aminolevulinic acid synthase, the first enzyme in the heme biosynthesis. Thus, a deficiency in HMBS activity results in an overproduction of porphyrin precursors and the clinical manifestation of the disease. Early diagnosis and counselling are essential to prevent attacks, and mutation analysis is the most accurate method to identify asymptomatic carriers in AIP families. In the present study, we have investigated the molecular defects in 55 unrelated Spanish patients with AIP, identifying 32 HMBS gene mutations, of which six were novel and ten were found in more than one patient. The novel mutations included a missense, an insertion, two deletions, and two splice site variants. Prokaryotic expression studies demonstrated the detrimental effect for the missense mutation, whereas reverse transcription-PCR and sequencing showed aberrant splicing caused by each splice site mutation. These results will allow for an accurate diagnosis of carriers of the disease in these families. Furthermore, they increase the knowledge about the molecular heterogeneity of AIP in Spain.


1994 ◽  
Vol 3 (4) ◽  
pp. 671-673 ◽  
Author(s):  
Paul Coucke ◽  
Lleve Vits ◽  
Guy Van Camp ◽  
Francoise Serville ◽  
Stanislas Lyonnet ◽  
...  

Meta Gene ◽  
2016 ◽  
Vol 9 ◽  
pp. 47-51
Author(s):  
Kourtnee Hoitsema ◽  
Dominick Amato ◽  
Aneal Khan ◽  
Sandra Sirrs ◽  
Francis Y.M. Choy

Sign in / Sign up

Export Citation Format

Share Document